亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

濟南宏方德醫(yī)藥科技有限公司  

恩替卡韋一水合物、釓噴酸、釓噴酸單匍銨、鹽酸特比萘芬、紐甜、吉西他濱、替莫普利、2,3-環(huán)戊烯并吡啶、氨基丙醛、硝酸舍他康唑、

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:姚璐佳
  • 電話:0531-55505896
  • 郵件:hfdchem@yahoo.com.cn
  • 傳真:0531-88873618
  • QQ:541766821
站內(nèi)搜索
 
榮譽資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產(chǎn)品 > 鹽酸左氧氟沙星
鹽酸左氧氟沙星
單價 1.00 / 公斤對比
銷量 暫無
發(fā)貨 山東濟南市付款后3天內(nèi)
庫存 1000公斤起訂1公斤
品牌 山東宏富達
型號 100986-85-4
規(guī)格 企標
過期 長期有效
更新 2011-06-30 15:48
 
詳細信息
英文名  
Levofloxacin
別名
 
LVFX; RWJ 25213; L-Ofloxacin; Ophthalmic; (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazin-yl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
   
 
分子式  
C18H20FN3O4
分子量  
361.37
CAS 登錄號
 
100986-85-4
中文名 鹽酸左氧氟沙星
©2025 濟南宏方德醫(yī)藥科技有限公司 版權(quán)所有   技術支持:化工網(wǎng)   訪問量:9904  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |